649 related articles for article (PubMed ID: 18479783)
1. Defects in IGF-1 receptor, insulin receptor and IRS-1/2 in Alzheimer's disease indicate possible resistance to IGF-1 and insulin signalling.
Moloney AM; Griffin RJ; Timmons S; O'Connor R; Ravid R; O'Neill C
Neurobiol Aging; 2010 Feb; 31(2):224-43. PubMed ID: 18479783
[TBL] [Abstract][Full Text] [Related]
2. Neuronal IGF-1 resistance reduces Abeta accumulation and protects against premature death in a model of Alzheimer's disease.
Freude S; Hettich MM; Schumann C; Stöhr O; Koch L; Köhler C; Udelhoven M; Leeser U; Müller M; Kubota N; Kadowaki T; Krone W; Schröder H; Brüning JC; Schubert M
FASEB J; 2009 Oct; 23(10):3315-24. PubMed ID: 19487308
[TBL] [Abstract][Full Text] [Related]
3. The diabetes drug liraglutide ameliorates aberrant insulin receptor localisation and signalling in parallel with decreasing both amyloid-β plaque and glial pathology in a mouse model of Alzheimer's disease.
Long-Smith CM; Manning S; McClean PL; Coakley MF; O'Halloran DJ; Holscher C; O'Neill C
Neuromolecular Med; 2013 Mar; 15(1):102-14. PubMed ID: 23011726
[TBL] [Abstract][Full Text] [Related]
4. The role of IGF-1 receptor and insulin receptor signaling for the pathogenesis of Alzheimer's disease: from model organisms to human disease.
Freude S; Schilbach K; Schubert M
Curr Alzheimer Res; 2009 Jun; 6(3):213-23. PubMed ID: 19519303
[TBL] [Abstract][Full Text] [Related]
5. Blocking IGF Signaling in Adult Neurons Alleviates Alzheimer's Disease Pathology through Amyloid-β Clearance.
Gontier G; George C; Chaker Z; Holzenberger M; Aïd S
J Neurosci; 2015 Aug; 35(33):11500-13. PubMed ID: 26290229
[TBL] [Abstract][Full Text] [Related]
6. The role of neuronal insulin/insulin-like growth factor-1 signaling for the pathogenesis of Alzheimer's disease: possible therapeutic implications.
Zemva J; Schubert M
CNS Neurol Disord Drug Targets; 2014 Mar; 13(2):322-37. PubMed ID: 24059318
[TBL] [Abstract][Full Text] [Related]
7. Demonstrated brain insulin resistance in Alzheimer's disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline.
Talbot K; Wang HY; Kazi H; Han LY; Bakshi KP; Stucky A; Fuino RL; Kawaguchi KR; Samoyedny AJ; Wilson RS; Arvanitakis Z; Schneider JA; Wolf BA; Bennett DA; Trojanowski JQ; Arnold SE
J Clin Invest; 2012 Apr; 122(4):1316-38. PubMed ID: 22476197
[TBL] [Abstract][Full Text] [Related]
8. Insulin receptor signaling mediates APP processing and β-amyloid accumulation without altering survival in a transgenic mouse model of Alzheimer's disease.
Stöhr O; Schilbach K; Moll L; Hettich MM; Freude S; Wunderlich FT; Ernst M; Zemva J; Brüning JC; Krone W; Udelhoven M; Schubert M
Age (Dordr); 2013 Feb; 35(1):83-101. PubMed ID: 22057897
[TBL] [Abstract][Full Text] [Related]
9. Insulin-like growth factor-1 (IGF-1) receptor-insulin receptor substrate complexes in the uterus. Altered signaling response to estradiol in the IGF-1(m/m) mouse.
Richards RG; Walker MP; Sebastian J; DiAugustine RP
J Biol Chem; 1998 May; 273(19):11962-9. PubMed ID: 9565625
[TBL] [Abstract][Full Text] [Related]
10. Differential involvement of insulin receptor substrate (IRS)-1 and IRS-2 in brain insulin signaling is associated with the effects on amyloid pathology in a mouse model of Alzheimer's disease.
Ochiai T; Sano T; Nagayama T; Kubota N; Kadowaki T; Wakabayashi T; Iwatsubo T
Neurobiol Dis; 2021 Nov; 159():105510. PubMed ID: 34537327
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of insulin-like growth factor signaling pathways in mammary gland by pure antiestrogen ICI 182,780.
Chan TW; Pollak M; Huynh H
Clin Cancer Res; 2001 Aug; 7(8):2545-54. PubMed ID: 11489838
[TBL] [Abstract][Full Text] [Related]
12. Central insulin and insulin-like growth factor-1 signaling: implications for diabetes associated dementia.
Zemva J; Schubert M
Curr Diabetes Rev; 2011 Sep; 7(5):356-66. PubMed ID: 21916834
[TBL] [Abstract][Full Text] [Related]
13. IGF-1R, a target of let-7b, mediates crosstalk between IRS-2/Akt and MAPK pathways to promote proliferation of oral squamous cell carcinoma.
Gao L; Wang X; Wang X; Zhang L; Qiang C; Chang S; Ren W; Li S; Yang Y; Tong D; Chen C; Li Z; Song T; Zhi K; Huang C
Oncotarget; 2014 May; 5(9):2562-74. PubMed ID: 24810113
[TBL] [Abstract][Full Text] [Related]
14. erbB3 recruitment of insulin receptor substrate 1 modulates insulin-like growth factor receptor signalling in oestrogen receptor-positive breast cancer cell lines.
Knowlden JM; Gee JM; Barrow D; Robertson JF; Ellis IO; Nicholson RI; Hutcheson IR
Breast Cancer Res; 2011 Sep; 13(5):R93. PubMed ID: 21939528
[TBL] [Abstract][Full Text] [Related]
15. Curcumin regulates insulin pathways and glucose metabolism in the brains of APPswe/PS1dE9 mice.
Wang P; Su C; Feng H; Chen X; Dong Y; Rao Y; Ren Y; Yang J; Shi J; Tian J; Jiang S
Int J Immunopathol Pharmacol; 2017 Mar; 30(1):25-43. PubMed ID: 28124574
[TBL] [Abstract][Full Text] [Related]
16. Disruption of the insulin-like growth factor type 1 receptor in osteoblasts enhances insulin signaling and action.
Fulzele K; DiGirolamo DJ; Liu Z; Xu J; Messina JL; Clemens TL
J Biol Chem; 2007 Aug; 282(35):25649-58. PubMed ID: 17553792
[TBL] [Abstract][Full Text] [Related]
17. Improved Brain Insulin/IGF Signaling and Reduced Neuroinflammation with T3D-959 in an Experimental Model of Sporadic Alzheimer's Disease.
de la Monte SM; Tong M; Schiano I; Didsbury J
J Alzheimers Dis; 2017; 55(2):849-864. PubMed ID: 27802237
[TBL] [Abstract][Full Text] [Related]
18. Connective tissue growth factor (CTGF) expression in the brain is a downstream effector of insulin resistance- associated promotion of Alzheimer's disease beta-amyloid neuropathology.
Zhao Z; Ho L; Wang J; Qin W; Festa ED; Mobbs C; Hof P; Rocher A; Masur S; Haroutunian V; Pasinetti GM
FASEB J; 2005 Dec; 19(14):2081-2. PubMed ID: 16186174
[TBL] [Abstract][Full Text] [Related]
19. Compensatory insulin receptor (IR) activation on inhibition of insulin-like growth factor-1 receptor (IGF-1R): rationale for cotargeting IGF-1R and IR in cancer.
Buck E; Gokhale PC; Koujak S; Brown E; Eyzaguirre A; Tao N; Rosenfeld-Franklin M; Lerner L; Chiu MI; Wild R; Epstein D; Pachter JA; Miglarese MR
Mol Cancer Ther; 2010 Oct; 9(10):2652-64. PubMed ID: 20924128
[TBL] [Abstract][Full Text] [Related]
20. Genetic engineering in mice: impact on insulin signalling and action.
Lamothe B; Baudry A; Desbois P; Lamotte L; Bucchini D; De Meyts P; Joshi RL
Biochem J; 1998 Oct; 335 ( Pt 2)(Pt 2):193-204. PubMed ID: 9761714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]